| Manager | Title | Age | Since |
|---|---|---|---|
Ola Holmlund
CEO | Chief Executive Officer | 57 | 01/01/2018 |
Jan Holmbäck
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/01/2010 |
Charlotta Ekman
DFI | Director of Finance/CFO | 45 | 01/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ola Flink
CHM | Chairman | 82 | 01/01/2017 |
| Chairman | 46 | 01/01/2020 | |
Gunilla Lundmark
BRD | Director/Board Member | 63 | 01/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -98.73% | - | - | 92.63K | |
| +0.02% | +4.44% | +48.23% | +163.27% | 1,067B | |
| +1.58% | +7.61% | +61.09% | +54.16% | 635B | |
| +0.25% | +2.75% | +38.11% | +74.91% | 458B | |
| +1.41% | +8.56% | +38.18% | +32.17% | 347B | |
| +1.28% | +4.40% | +37.69% | +41.62% | 295B | |
| +1.72% | +4.10% | +19.44% | +20.45% | 262B | |
| +1.84% | -0.46% | -27.63% | -38.65% | 216B | |
| +0.51% | +3.89% | +25.58% | +60.28% | 203B | |
| +1.59% | -1.12% | +16.53% | +72.15% | 161B | |
| Average | +1.14% | +1.33% | +28.58% | +53.37% | 404.83B | |
| Weighted average by Cap. | +0.98% | +1.95% | +38.16% | +78.81% |
Employees
4
Sector
Pharmaceuticals
